Samatasvir

DB12660InvestigationalSmall molecule

Samatasvir has been used in trials studying the treatment of Hepatitis C, Chronic, Chronic Hepatitis C Virus, and Chronic Hepatitis C Infection.

Chemical structure of Samatasvir
Mechanism
Curator reviewed
Formula / weight
C47H48N8O6S2 · 885.07 g/mol (avg)
Code names
IDX-18719

Resolves to

Compound
UNII21P699C5FCCAS1312547-19-5ChEMBLCHEMBL3039519PubChem58310140
Structure
InChIKeyATOLIHZIXHZSBA-BTSKBWHGSA-NSMILESCOC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C1=NC2=CC=C(C=C2N1)C1=CSC2=C1SC=C2C1=CC=C(C=C1)C1=CN=C(N1)[C@@H]1CCCN1C(=O)[C@H](NC(=O)OC)C1=CC=CC=C1
Targets
Q5L478NS5A

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Samatasvir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In